Relationship of Iron Deposition to Calcium Deposition in Human Aortic Valve Leaflets.


Journal

Journal of the American College of Cardiology
ISSN: 1558-3597
Titre abrégé: J Am Coll Cardiol
Pays: United States
ID NLM: 8301365

Informations de publication

Date de publication:
12 03 2019
Historique:
received: 18 06 2018
revised: 08 11 2018
accepted: 02 12 2018
entrez: 9 3 2019
pubmed: 9 3 2019
medline: 24 1 2020
Statut: ppublish

Résumé

Intraleaflet hematomas are associated with advanced stages of aortic valve calcification and suspected to be involved in disease progression. However, the mechanism by which the entry of blood cells into the valves affects the biology of aortic valvular interstitial cells (VICs) remains to be elucidated. This study sought to evaluate the putative link between intraleaflet hematoma and aortic valve calcification and to assess its pathophysiological implications. The spatial relationship between calcium deposits and intraleaflet hematomas was analyzed by whole-mount staining of calcified and noncalcified human aortic valves, obtained in the context of heart transplantation and from patients who underwent surgical valve replacement. Endothelial microfissuring was evaluated by en face immunofluorescence and scanning electron microscopic analyses of the fibrosa surface. Red blood cell (RBC) preparations were used in vitro to assess, by immunofluorescence microscopy and Alizarin red staining, the potential impact of intraleaflet hematomas on phenotypic changes in VICs. Intraleaflet hematomas, revealed by iron deposits and RBCs into the fibrosa, secondary to endothelial microfissuring, were consistently found in noncalcified valves. The contact of primary VICs derived from these valves with RBCs resulted in a global inflammatory and osteoblastic phenotype, reflected by the up-regulation of interleukin-6, interleukin-1β, bone sialoprotein, osteoprotegerin, receptor activator of nuclear factor kappa B, bone morphogenic protein 2, and muscle segment homeobox 2, the production of osteocalcin, and the formation of calcium deposits. The acquisition of an osteoblastic phenotype in VICs that come into contact with the senescent RBCs of intraleaflet hematomas may play a critical role in the initiation of calcium deposition into the fibrosa of human aortic valves.

Sections du résumé

BACKGROUND
Intraleaflet hematomas are associated with advanced stages of aortic valve calcification and suspected to be involved in disease progression. However, the mechanism by which the entry of blood cells into the valves affects the biology of aortic valvular interstitial cells (VICs) remains to be elucidated.
OBJECTIVES
This study sought to evaluate the putative link between intraleaflet hematoma and aortic valve calcification and to assess its pathophysiological implications.
METHODS
The spatial relationship between calcium deposits and intraleaflet hematomas was analyzed by whole-mount staining of calcified and noncalcified human aortic valves, obtained in the context of heart transplantation and from patients who underwent surgical valve replacement. Endothelial microfissuring was evaluated by en face immunofluorescence and scanning electron microscopic analyses of the fibrosa surface. Red blood cell (RBC) preparations were used in vitro to assess, by immunofluorescence microscopy and Alizarin red staining, the potential impact of intraleaflet hematomas on phenotypic changes in VICs.
RESULTS
Intraleaflet hematomas, revealed by iron deposits and RBCs into the fibrosa, secondary to endothelial microfissuring, were consistently found in noncalcified valves. The contact of primary VICs derived from these valves with RBCs resulted in a global inflammatory and osteoblastic phenotype, reflected by the up-regulation of interleukin-6, interleukin-1β, bone sialoprotein, osteoprotegerin, receptor activator of nuclear factor kappa B, bone morphogenic protein 2, and muscle segment homeobox 2, the production of osteocalcin, and the formation of calcium deposits.
CONCLUSIONS
The acquisition of an osteoblastic phenotype in VICs that come into contact with the senescent RBCs of intraleaflet hematomas may play a critical role in the initiation of calcium deposition into the fibrosa of human aortic valves.

Identifiants

pubmed: 30846099
pii: S0735-1097(19)30105-6
doi: 10.1016/j.jacc.2018.12.042
pii:
doi:

Substances chimiques

Iron E1UOL152H7
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1043-1054

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Auteurs

Marion Morvan (M)

National Institute of Health and Medical Research U1148, Paris, France.

Dimitri Arangalage (D)

National Institute of Health and Medical Research U1148, Paris, France; Department of Cardiology, Bichat Hospital, Paris, France; Faculty of Medicine Paris-Diderot, University Paris Diderot, Sorbonne Paris Cité, Paris, France.

Grégory Franck (G)

National Institute of Health and Medical Research U1148, Paris, France.

Fanny Perez (F)

National Institute of Health and Medical Research U1148, Paris, France.

Léa Cattan-Levy (L)

National Institute of Health and Medical Research U1148, Paris, France; Department of Cardiology, Bichat Hospital, Paris, France.

Isabelle Codogno (I)

Department of Cardiology, Bichat Hospital, Paris, France.

Marie-Paule Jacob-Lenet (MP)

National Institute of Health and Medical Research U1148, Paris, France.

Catherine Deschildre (C)

National Institute of Health and Medical Research U1148, Paris, France.

Christine Choqueux (C)

National Institute of Health and Medical Research U1148, Paris, France.

Guillaume Even (G)

National Institute of Health and Medical Research U1148, Paris, France.

Jean-Baptiste Michel (JB)

National Institute of Health and Medical Research U1148, Paris, France.

Magnus Bäck (M)

Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.

David Messika-Zeitoun (D)

National Institute of Health and Medical Research U1148, Paris, France; Department of Cardiology, Bichat Hospital, Paris, France; Faculty of Medicine Paris-Diderot, University Paris Diderot, Sorbonne Paris Cité, Paris, France.

Antonino Nicoletti (A)

National Institute of Health and Medical Research U1148, Paris, France; Faculty of Medicine Paris-Diderot, University Paris Diderot, Sorbonne Paris Cité, Paris, France.

Giuseppina Caligiuri (G)

National Institute of Health and Medical Research U1148, Paris, France; Department of Cardiology, Bichat Hospital, Paris, France. Electronic address: giuseppina.caligiuri@inserm.fr.

Jamila Laschet (J)

National Institute of Health and Medical Research U1148, Paris, France; Faculty of Medicine Paris-Diderot, University Paris Diderot, Sorbonne Paris Cité, Paris, France. Electronic address: jamila.laschet@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH